Jane Holl to Liver Cirrhosis
This is a "connection" page, showing publications Jane Holl has written about Liver Cirrhosis.
Connection Strength
0.213
-
Mortality Risk Factors Among Patients With Cirrhosis and a Low Model for End-Stage Liver Disease Sodium Score (=15): An Analysis of Liver Transplant Allocation Policy Using Aggregated Electronic Health Record Data. Am J Transplant. 2017 Sep; 17(9):2410-2419.
Score: 0.125
-
Transjugular intrahepatic portosystemic shunting is not superior to endoscopic variceal band ligation for prevention of variceal rebleeding in cirrhotic patients: a randomized, controlled trial. Scand J Gastroenterol. 2002 Mar; 37(3):338-43.
Score: 0.044
-
Renal effects of transjugular intrahepatic portosystemic shunt in cirrhosis: comparison of patients with ascites, with refractory ascites, or without ascites. Hepatology. 1998 Sep; 28(3):683-8.
Score: 0.034
-
A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. N Engl J Med. 2000 Jun 08; 342(23):1701-7.
Score: 0.010